Lv5
1246 积分 2024-10-24 加入
An Overview of the Mechanism of Action of the Monoclonal Antibody Vedolizumab
3个月前
已完结
The binding specificity and selective antagonism of vedolizumab, an anti-alpha4beta7 integrin therapeutic antibody in development for inflammatory bowel diseases
3个月前
已完结
Pharmacokinetics of S1P receptor modulators in the treatment of ulcerative colitis
4个月前
已完结
Correlation between biomarkers (calprotectin, seromucoid, metalloproteinase-3 and CRP) and clinical and endoscopic activity of ulcerative colitis in children
4个月前
已完结
Circulating levels of TNF-like cytokine 1A correlate with the progression of atheromatous lesions in patients with rheumatoid arthritis
4个月前
已完结
Expression of MAdCAM-1 and Gut-homing T Cells in Inflamed Pouch Mucosa
5个月前
已完结
Ozanimod as Induction and Maintenance Therapy for Ulcerative Colitis
7个月前
已完结
Ozanimod: A First-in-Class Sphingosine 1-Phosphate Receptor Modulator for the Treatment of Ulcerative Colitis
7个月前
已完结
Pharmacokinetics of S1P receptor modulators in the treatment of ulcerative colitis
7个月前
已完结
Clinical pharmacokinetics and pharmacodynamics of oral systemic nonbiologic therapies for psoriasis patients
7个月前
已完结
皖公网安备34019202002308
